Suppliers and packagers for RISPERDAL

RISPERDAL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Janssen Pharms	RISPERDAL	risperidone	SOLUTION;ORAL	020588	NDA	Janssen Pharmaceuticals, Inc.	50458-305-03	30 mL in 1 BOTTLE (50458-305-03)	1996-06-10
Janssen Pharms	RISPERDAL	risperidone	SOLUTION;ORAL	020588	NDA	Janssen Pharmaceutical, Inc.	50458-596-01	30 mL in 1 BOTTLE (50458-596-01)	1996-06-10
Janssen Pharms	RISPERDAL	risperidone	SOLUTION;ORAL	020588	NDA	REMEDYREPACK INC.	70518-3760-0	10 CUP, UNIT-DOSE in 1 BOX (70518-3760-0) / 2 mL in 1 CUP, UNIT-DOSE (70518-3760-1)	2023-06-12

Suppliers for the Pharmaceutical Drug: RISPERDAL

Last updated: July 30, 2025

Introduction

Risperdal, the brand name for risperidone, is an atypical antipsychotic medication primarily used to manage schizophrenia, bipolar disorder, and irritability associated with autism. As a vital therapeutic agent, Risperdal's manufacturing and distribution involve a complex global supply chain comprising raw material providers, API (Active Pharmaceutical Ingredient) manufacturers, formulation specialists, and packaging firms. Ensuring a consistent and high-quality supply chain is paramount for maintaining drug availability, regulatory compliance, and patient safety. This report examines the main suppliers involved across various stages of Risperdal's production, analyzing their roles, geographic distribution, and impact on the pharmaceutical market.

Raw Material Suppliers for Risperdal

Active Pharmaceutical Ingredient (API) Manufacturers

The cornerstone of Risperdal's production is the risperidone API. Leading API manufacturers supply pharmaceutical companies with high-purity risperidone for formulation. Notable API suppliers include:

• Hetero Labs Limited (India):
  One of the most prominent risperidone API producers globally, Hetero Labs supplies large volumes to generic pharmaceutical firms. Its facilities are WHO-GMP certified, and the company emphasizes rigorous quality controls aligning with international standards[1].

• Jiangsu Hengrui Medicine Co., Ltd. (China):
  As a leading Chinese pharmaceutical enterprise, Hengrui supplies risperidone API to both domestic and international markets. Its manufacturing adheres to cGMP standards, ensuring baseline quality for global distribution[2].

• Sichuan Kelun Pharmaceutical Co., Ltd. (China):
  Kelun manufactures risperidone API with a focus on cost-effectiveness and quality assurance, serving markets across Asia, Europe, and North America.

• Teva Pharmaceutical Industries Ltd. (Israel):
  As a key players in generic drug manufacturing, Teva also produces risperidone API, leveraging integrated supply chain capabilities[3].

Raw Materials for API Synthesis

The synthesis of risperidone involves multiple chemical precursors, supplied primarily by chemical raw material companies specializing in intermediates such as piperidones, heteroaryl compounds, and methylating agents. Major suppliers include:

• Lanxess AG (Germany): Provides specialized chemicals and intermediates used in risperidone synthesis, including heteroaromatic compounds[4].

• BASF (Germany): Supplies solvents and intermediates essential to API manufacturing processes.

• Local Chinese chemical suppliers: Many supply chain segments are dominated by regional suppliers offering cost-effective intermediates but with variable regulatory oversight.

Formulation and Finished Dosage Suppliers

Once the API is synthesized and purified, pharmaceutical companies proceed with formulation, filling, and packaging. Contract manufacturing organizations (CMOs) and proprietary manufacturers play significant roles here.

Major Formulation and Packaging Suppliers

• Sandoz (a Novartis division, Switzerland):
  Sandoz is a leading producer of generic Risperdal formulations. It operates manufacturing facilities in Europe and North America, ensuring compliance with stringent Good Manufacturing Practices (GMPs)[5].

• Mylan (Now part of Viatris):
  Mylan’s extensive global manufacturing network supplies Risperdal generic formulations across numerous markets, emphasizing cost-efficiency and quality[6].

• Sun Pharma (India):
  As a significant generic pharmaceutical manufacturer, Sun Pharma produces Risperdal formulations for Asian, African, and Latin American markets, often sourcing APIs from Indian suppliers.

• Teva Pharmaceutical Industries Ltd.:
  Besides API production, Teva supplies finished Risperdal formulations globally, highlighting vertical integration.

Packaging and Distribution Partnerships

Drug packaging often involves contracted vendors specializing in blister packs, bottles, and labeling compliant with regulatory standards. Major vendors include:

• Essentra Packaging (UK):
  Supplies blister packs and bottles compliant with international standards.

• Gerresheimer (Germany):
  Provides primary packaging solutions including glass and plastic containers.

• Local contract packagers:
  Regional companies often handle final packaging closer to distribution points to optimize logistics and compliance.

Regulatory and Market Considerations Impacting Suppliers

The global supply chain for Risperdal is shaped by various regulatory requirements such as cGMP, ISO standards, and regional approvals. Markets such as the US, EU, and Japan enforce strict quality control, often limiting the number of approved suppliers, especially for APIs. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) regularly audit API manufacturers, influencing supply stability and market access.

Regional production hubs in India and China dominate the API supply landscape, driven by lower manufacturing costs but accompanied by quality assurance challenges. Approved suppliers must meet stringent certifications, and some pharmaceutical companies prefer to work with established, globally recognized API manufacturers to mitigate regulatory risks.

Market Dynamics and Future Trends

The Risperdal supply chain constantly evolves under market and regulatory pressures. Patent expirations have expanded the number of generic manufacturers, resulting in increased competition and diversified sourcing.

• Globalization of API Manufacturing:
  The shift towards Asia for cost-effective API production continues, with Chinese and Indian suppliers capturing significant market share.

• Supply Chain Resilience:
  Recent disruptions, such as the COVID-19 pandemic, have spotlighted vulnerabilities in the supply chain, prompting companies to diversify suppliers and geographic sources.

• Regulatory Stringency and Quality Standards:
  Increasingly strict quality standards have led suppliers to invest in advanced manufacturing technologies and certifications to retain market access.

• Environmental and Social Governance (ESG):
  Sustainability and responsible sourcing are becoming integral, influencing supplier selection, especially for multinational pharmaceutical firms.

Key Takeaways

• Leading API Suppliers: Hetero Labs (India), Jiangsu Hengrui (China), and Teva are primary risperidone API manufacturers, with certifications aligning with global standards.

• Formulation and Packaging: Major generics firms such as Sandoz, Mylan, and Sun Pharma dominate formulation, leveraging global manufacturing networks to meet regional demands.

• Regional Concentration: Asia, particularly China and India, forms the backbone of Risperdal’s raw material and API supply chains, driven by cost advantages and evolving regulatory compliance.

• Market and Regulatory Impact: Strict regulatory oversight influences supplier qualification, product quality, and market access, emphasizing the importance of compliance across the supply chain.

• Future Outlook: Supply chain resilience, diversification, and adherence to ESG principles will continue to shape Risperdal's supplier landscape, influencing pricing, availability, and quality standards.

---

FAQs

1. Who are the primary global suppliers of risperidone API?
Hetero Labs (India), Jiangsu Hengrui (China), and Teva (Israel) are among the leading global suppliers of risperidone API, each meeting international quality standards for pharmaceutical manufacturing.

2. How does regional manufacturing impact the quality of Risperdal?
While manufacturing in regions like India and China offers cost benefits, suppliers must meet rigorous GMP standards and regulatory certifications. Approved suppliers with strong quality assurance mechanisms ensure product consistency and safety.

3. Are there alternative suppliers for Risperdal’s raw materials?
Yes, numerous regional chemical suppliers provide intermediates and raw materials for risperidone synthesis. However, pharmaceutical companies typically prefer suppliers with validated quality records and regulatory approvals to mitigate compliance risks.

4. How does regulation influence Risperdal's supply chain?
Regulatory bodies such as the FDA and EMA enforce stringent standards for APIs and finished dosage forms. Compliance requirements influence supplier qualification, manufacturing practices, and ultimately, drug availability.

5. What trends could affect the future supplier landscape for Risperdal?
Global supply chain resilience, regulatory tightening, sustainability initiatives, and technological advancements will likely diversify and stabilize supplier networks, potentially leading to more localized manufacturing hubs and increased quality standards.

---

References

[1] Hetero Labs Limited. "Our Manufacturing Facilities." Hetero.com.
[2] Jiangsu Hengrui Medicine Co., Ltd. "Corporate Profile." Hengrui.com.
[3] Teva Pharmaceutical Industries Ltd. "API and Formulation Manufacturing." Teva.co.il.
[4] Lanxess AG. "Specialty Chemicals and Intermediates." Lanxess.com.
[5] Novartis Sandoz. "Generics Portfolio." Sandoz.com.
[6] Viatris (formerly Mylan). "Product Offerings." Viatris.com.